Survivorship Care Plan Implementation in US Cancer Programs: a National Survey of Cancer Care Providers.


Journal

Journal of cancer education : the official journal of the American Association for Cancer Education
ISSN: 1543-0154
Titre abrégé: J Cancer Educ
Pays: England
ID NLM: 8610343

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 28 6 2018
medline: 11 6 2020
entrez: 28 6 2018
Statut: ppublish

Résumé

Survivorship care plans (SCPs)-documents intended to improve care for cancer survivors who have completed active treatment-are required, yet implementation is poor. We sought to understand SCP implementation in cancer programs in the USA with the objective of identifying opportunities for improvement. We recruited cancer care providers in the USA via several cancer care networks to participate in a survey regarding SCP implementation. We used descriptive statistics to analyze the data. Three hundred ninety-five providers from diverse cancer programs in 47 states and Washington, DC responded to the survey. The timing of SCP implementation varied across and within cancer programs, with approximately 40% of respondents reporting developing SCPs more than 3 months after primary treatment or adjuvant therapy completion. Nurse navigators were responsible for 48-58% of each stage of SCP implementation. Processes that could have been automated often occurred in-person or via phone and vice versa. Respondents reported spending more than 2 h per SCP to complete all stages of implementation, of which less than a third was reimbursed by third-party payers. We identified several opportunities for improving SCP implementation, including broadening the base of responsibility, optimizing modes of communication, decreasing the time required and increasing the funding available, and limiting variation in SCP implementation across and within cancer programs. Future work should assess the influence of approaches to SCP implementation on desired outcomes.

Identifiants

pubmed: 29948925
doi: 10.1007/s13187-018-1374-0
pii: 10.1007/s13187-018-1374-0
pmc: PMC6294719
mid: NIHMS968317
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

614-622

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR001109
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001876
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR002490
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

Semin Oncol Nurs. 2001 Nov;17(4):241-8
pubmed: 11764707
Patient Educ Couns. 2005 Jun;57(3):342-9
pubmed: 15893218
Acad Med. 2005 Dec;80(12):1094-9
pubmed: 16306279
J Clin Oncol. 2007 Jun 1;25(16):2270-3
pubmed: 17538172
J Clin Oncol. 2009 May 20;27(15):2489-95
pubmed: 19332716
J Oncol Pract. 2010 Jul;6(4):174-81
pubmed: 21037867
Cancer Nurs. 2011 May-Jun;34(3):E1-10
pubmed: 21045754
J Clin Oncol. 2011 Dec 20;29(36):4755-62
pubmed: 22042959
J Oncol Pract. 2011 Sep;7(5):314-8
pubmed: 22211129
CA Cancer J Clin. 2012 Mar-Apr;62(2):101-17
pubmed: 22241452
Support Care Cancer. 2012 Jul;20(7):1579-83
pubmed: 22526150
Patient Educ Couns. 2012 Sep;88(3):427-35
pubmed: 22658248
CA Cancer J Clin. 2012 Jul-Aug;62(4):220-41
pubmed: 22700443
J Oncol Pract. 2012 Jul;8(4):246-52
pubmed: 23180991
Arch Otolaryngol Head Neck Surg. 2012 Dec;138(12):1116-9
pubmed: 23247230
J Clin Oncol. 2013 Feb 10;31(5):631-40
pubmed: 23295805
Gynecol Oncol. 2013 Jun;129(3):554-8
pubmed: 23474344
J Cancer Educ. 2013 Jun;28(2):290-6
pubmed: 23526552
Breast Cancer Res Treat. 2013 Apr;138(3):795-806
pubmed: 23542954
Cancer. 2013 Dec 15;119(24):4316-24
pubmed: 24105101
J Oncol Pract. 2014 Mar;10(2):e86-92
pubmed: 24326740
J Cancer Educ. 2014 Dec;29(4):689-97
pubmed: 24577781
J Cancer Educ. 2014 Dec;29(4):720-7
pubmed: 24706174
J Cancer Surviv. 2015 Dec;9(4):683-91
pubmed: 25896265
J Clin Oncol. 2015 Nov 1;33(31):3550-9
pubmed: 26304900
Cancer. 2016 Mar 15;122(6):908-16
pubmed: 26650715
Gynecol Oncol. 2017 May;145(2):319-328
pubmed: 28283195

Auteurs

Sarah A Birken (SA)

Department of Health Policy and Management, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, 1103E McGavran-Greenberg, 135 Dauer Drive, Campus Box 7411, Chapel Hill, NC, 27599-7411, USA. birken@unc.edu.

Sarah Raskin (S)

L. Douglas Wilder School of Government and Public Affairs, Virginia Commonwealth University, Richmond, VA, USA.

Yuqing Zhang (Y)

Institute for Patient-Centered Initiatives & Health Equity, The George Washington University Cancer Center, Washington, DC, USA.

Gema Lane (G)

Institute for Patient-Centered Initiatives & Health Equity, The George Washington University Cancer Center, Washington, DC, USA.

Alexandra Zizzi (A)

Department of Health Policy and Management, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, 1103E McGavran-Greenberg, 135 Dauer Drive, Campus Box 7411, Chapel Hill, NC, 27599-7411, USA.

Mandi Pratt-Chapman (M)

Institute for Patient-Centered Initiatives & Health Equity, The George Washington University Cancer Center, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH